Skip to content

Comparing Hypertension Remote Monitoring Evaluation Redesign

Comparing Hypertension Remote Monitoring Evaluation Redesign

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06113458
Acronym
CHARMED
Enrollment
2500
Registered
2023-11-02
Start date
2024-10-21
Completion date
2028-07-01
Last updated
2026-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Brief summary

The goal of this clinical trial is to compare the effectiveness of evidence-based, adapted, and tailored, patient-focused and clinic-focused strategies to improve blood pressure (BP) control in English- and Spanish-speaking patients with hypertension (HTN).

Interventions

BEHAVIORALStandard and One-time Training

Patient-level intervention: Patients in the standard group will receive automated reminder SMS text messages and remote BP monitoring. Clinic-level intervention: Clinics in the one-time training group will receive one-time training on standard work and algorithms, audit and feedback, and panel-based outreach.

BEHAVIORALStandard and Practice Facilitation

Patient-level intervention: Patients in the standard group will receive automated reminder SMS text messages and remote BP monitoring. Clinic-level intervention: Clinics in the practice facilitation group will receive regular/ongoing training on standard work and algorithms, audit and feedback, and panel-based outreach.

BEHAVIORALHigh-intensity and One-time Training

Patient-level intervention: Patients in the high-intensity group will receive personalized feedback SMS text messages and remote BP monitoring. Clinic-level intervention: Clinics in the one-time training group will receive one-time training on standard work and algorithms, audit and feedback, and panel-based outreach.

BEHAVIORALHigh-intensity and Practice Facilitation

Patient-level intervention: Patients in the high-intensity group will receive personalized feedback SMS text messages and remote BP monitoring. Clinic-level intervention: Clinics in the practice facilitation group will receive regular/ongoing training on standard work and algorithms, audit and feedback, and panel-based outreach.

Sponsors

University of California, San Francisco
Lead SponsorOTHER
Patient-Centered Outcomes Research Institute
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years or older * Any sex/gender * Any race or ethnicity * Have hypertension or high blood pressure (BP) (BP \>=140/90 mmHg at least twice in the previous 18 months) * Can read and write English or Spanish * Be able to provide consent

Exclusion criteria

• We will exclude individuals with conditions that might have severe self-management limitations due to a disability or medical condition or might complicate remote BP monitoring, such as self-reported: * Pregnancy * Lactating/nursing * Dialysis

Design outcomes

Primary

MeasureTime frameDescription
Change in systolic BP (clinic)Baseline, 6 monthsClinic-based BP readings in EHR

Secondary

MeasureTime frameDescription
Change in systolic BP (home)Baseline, 6 monthsHome-based BP readings
Patient activation and satisfactionBaseline, 6 monthsPatients will complete the Patient Assessment of Chronic Illness Care (PACIC) survey of 20 questions regarding elements of the care of their chronic condition(s) over the last six months. Patients answer using a Likert scale of answers ranging from 1-5, with 1 signifying "Almost Never" and 5 signifying "Almost Always".
Number of participants with BP controlBaseline, 6 months\<140/90mmHg, at the patient level within the EHR
Medication intensification when BP is uncontrolledBaseline, 6 monthsNumber of classes of anti-hypertensive medications prescribed per patient
Patient-reported medication adherenceBaseline, 6 monthsPatients will complete the 4-item Krousel-Wood Medication Adherence Scale (M-Wood-MAS-4). The scale score is calculated by summing the points for the 4 questions (scale score ranges from 0 to 4, with higher score indicating worse adherence); low adherence on the K-Wood-MAS-4 is defined as a score ≥1.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORUrmimala Sarkar

University of California, San Francisco

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026